时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Acute central nervous system (CNS) injuries, including ischemic stroke, traumatic brain injury, and spinal cord injury, are characterized by profound mitochondrial dysfunction that drives secondary neuronal damage through ATP depletion,…
方法
Neuronal survival is critically dependent on mitochondrial integrity, making bioenergetic failure a central determinant of injury progression.
核心结论
In this context, intercellular mitochondria transfer has emerged as a potential adaptive mechanism through which functional mitochondria are delivered from donor cells-primarily astrocytes, microglia, and mesenchymal stem cells-to metabolically compromised…；Mitochondria transfer occurs via both contact-dependent pathways, such as tunneling nanotubes, and contact-independent mechanisms, including extracellular vesicles and free mitochondrial release.；These processes are regulated by signaling pathways such as CD38/cADPR-mediated calcium flux and MIRO1-dependent mitochondrial trafficking, facilitating organelle mobilization and uptake.
局限
It further highlights key limitations and knowledge gaps that must be addressed to determine whether mitochondria transfer can be effectively harnessed as a clinically viable strategy for neuro-restoration.
对本项目的价值
临床前机制证据，需评估物种外推与剂量可行性：线粒体是衰老干预的共同下游效应器，可用于跨器官效应的统一读数。 ｜ 价值分 1.9/5（★★☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：Intercellular Mitochondria Transfer as a Bioenergetic Rescue Mechanism in CNS Injury: Mechanisms, Therapeutic Potential, and Translational Barriers.
- 期刊与标识：Molecular neurobiology · PMID 42961624 · DOI 10.1007/s12035-026-06303-y
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。